Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,122 total articles
Syndax Pharmaceuticals Chief Financial Officer Keith A. Goldan sold 3,410 shares of common stock on February 9, 2026, at $21.028 per share to satisfy tax withholding related to vested restricted stock units. The transaction reduced a portion of his holdings while leaving him with 140,429 shares. The company recently showcased positive clinical resu…
Syndax Pharmaceuticals Chief Executive Officer Michael A. Metzger sold 17,159 shares on February 9, 2026, at $21.028 per share to meet tax withholding obligations tied to vesting restricted stock units. The transaction reduced no material ownership contextually; Metzger still holds 491,690 shares as the company draws positive analyst attention and …
Robert A. Schriesheim, a member of the board at Houlihan Lokey, sold 5,000 shares of Class A Common Stock at $170.86 per share on February 6, 2026, generating proceeds of $854,300. The transaction was disclosed in a Form 4 filed with the SEC on February 10, 2026. Separately, Houlihan Lokey reported fiscal third-quarter adjusted EPS of $1.94 and rev…
Merchants Bancorp Chairman and CEO Michael F. Petrie sold 21,759 Series C Depositary Shares across two trades in early February 2026, raising $439,531. The sales occurred as the stock traded near its 52-week high and after strong recent returns. Separately, the company’s board approved a $100 million repurchase program that runs through December 31…
A Ralliant Corp director filed a Form 4 disclosing a purchase of 2,000 common shares on February 9, 2026, at $41.25 per share, a transaction totaling $82,500. The buy comes after the stock fell about 24.76% over the prior week. The company disclosed a $1.44 billion goodwill impairment tied to its EA Elektro-Automatik business and trimmed 2026 guida…
Caterpillar Group President Bob De Lange executed option exercises and sold company stock on February 6, 2026, netting approximately $16.3 million from the sale of 22,656 shares. The moves followed the exercise of options to acquire 28,034 shares and occurred amid a fourth-quarter 2025 results beat in both earnings per share and revenue.
Director John B. Hansen sold 1,000 shares of Mueller Industries (MLI) on February 9, 2026, in a transaction valued at $116,710. The sale leaves Hansen with 90,664 directly held shares and 15,000 additional shares held indirectly through a family trust. Mueller reported fourth-quarter 2025 revenue growth alongside margin contraction and drew a price…
Lam Research director Eric Brandt sold 35,000 shares of the company's common stock on February 6, 2026, in two transactions totaling $7.8 million, according to a Form 4 filing. The semiconductor equipment maker recently posted fiscal second-quarter 2026 results that topped consensus, prompting analyst target increases, while also announcing executi…
Woodward director Eileen P. Paterson sold 5,200 shares of the company on February 5, 2026, for roughly $1.96 million and exercised options to acquire the same number of shares at $79.81. The moves coincided with the company reporting fiscal 2026 first-quarter earnings and revenues that surpassed analyst forecasts, and with shareholder approval of t…
Charles R. Guthrie, Vice Chairman of the Board of CB Financial Services (NASDAQ: CBFV), sold 1,913 shares of common stock on February 6, 2026, for roughly $71,450 and on the same day executed stock options to acquire 2,515 shares valued at $71,316. After these moves, Guthrie holds 16,796 shares directly and 6,901 shares indirectly. The bank reporte…
Automatic Data Processing Executive Vice President Brian L. Michaud sold 1,000 shares on February 6, 2026, under a pre-arranged Rule 10b5-1 plan adopted in September 2025, receiving $234.18 per share for proceeds of $234,180. The transaction leaves Michaud with 15,310.3519 shares directly. Separately, ADP reported fiscal Q2 2026 results that exceed…
John Rodney Messick, a director at Orrstown Financial Services, sold 2,500 shares on February 5, 2026, generating $96,550. The company reported fourth-quarter 2025 results that topped analyst estimates for both EPS and revenue, yet the stock fell in after-hours trading. Messick retains both immediately held common shares and restricted shares that …
Independent Bank Corp director John J. Morrissey sold 1,988 shares on February 6, 2026, for $85.70 each, netting $170,371. After the sale, Morrissey holds 12,747.078 shares, a total that includes 376.6224 shares accumulated through the company dividend reinvestment and stock purchase plan. The bank reported fourth-quarter 2025 results that exceeded…
SFS Holding Corp, a 10% owner of UWM Holdings Corp, sold 1,898,622 Class A shares from Feb. 5-9, 2026 under a pre-arranged 10b5-1 plan for roughly $9.2 million. The disposition occurred in three trades at $4.61 to $5.18 per share. After the sales SFS directly holds 3,692,273 shares. UWM’s stock has slid 8.86% over the prior week and is trading at $…
Spero Therapeutics' Chief Operating Officer Timothy Keutzer sold 18,652 shares on February 6, 2026 to satisfy tax-withholding obligations arising from RSU vesting. The company also disclosed a board departure, an agreement to retain the departing director as a consultant, the conclusion of an SEC inquiry with no enforcement action currently planned…
On February 6, 2026, Lem Scott C, serving as chief financial officer and treasurer of Ares Capital Corp (ARCC), bought 5,186 shares of the company's common stock for a total of $100,037. The purchase raises his direct stake to 39,463 shares. The business development company trades at a P/E of 10.46 and carries an approximate market capitalization o…
Patrick Industries director John A. Forbes reported a sale of 2,704 common shares on February 6, 2026, according to a Form 4 filing. The transaction, executed at a weighted average price of $140.7504, generated proceeds of $380,589. The disclosure comes amid a quarter in which the company outperformed earnings and revenue expectations for Q4 2025, …
Matthew S, Patrick Industries' senior vice president of finance and CAO, acquired 1,000 shares on February 6, 2026, at $139.915 per share, a purchase worth $139,915. The transaction increases his direct holdings to 20,614 shares. The stock trades modestly above the purchase price and near its 52-week high after the company reported fourth-quarter 2…
SoFi Technologies director Steven J. Freiberg sold 94,225 shares on February 6, 2026, receiving about $1.9 million, and simultaneously exercised options for 250,000 shares at $7.33 each. The stock has traded higher since the sale and analysts have issued mixed upgrades and price-target adjustments following stronger-than-expected fourth-quarter res…
Frank Keller, executive vice president at PayPal, disposed of 3,478 shares on February 6, 2026, under a pre-arranged 10b5-1 plan. The transaction and broader company performance coincide with a slowdown in Branded Checkout growth and a wave of analyst downgrades and price-target reductions reflecting concerns about transaction margins and execution…
Proto Labs Inc. (PRLB) reported that Chief Operations Officer Michael R. Kenison sold 2,500 shares on February 6, 2026, at $60.00 per share for proceeds of $150,000. The transaction was made under a Rule 10b5-1 trading plan adopted August 15, 2025, and was disclosed in a Form 4 filing with the SEC. Separately, the company released fourth-quarter 20…
Liberty Energy Inc. Chief Legal Officer Sean Elliott sold 25,000 Class A shares on February 6, 2026, at $25.40 per share for a total of $635,000. The sale coincides with the shares trading near their 52-week high and follows a series of corporate financing moves that include an increased convertible note offering and an amended credit agreement to …
Nurix Therapeutics Chief Legal Officer Christine Ring sold 14,261 shares of the company on February 9, 2026, under a pre-arranged Rule 10b5-1 plan for $237,618. The transaction came as the clinical-stage biotech drew a string of upward price-target revisions tied to progress on its bexobrutideg program and other clinical updates.
Netflix Chief Financial Officer Spencer Neumann sold 9,248 shares of company stock on February 6, 2026, raising roughly $751,597. The transaction was disclosed in an SEC Form 4 filed on February 9, 2026. The sale took place while Netflix shares trade near recent lows and as the company faces heightened regulatory and disclosure scrutiny tied to its…
Steve B Thompson, who serves as President and CEO of PrimeLending at Hilltop Holdings Inc (HTH), executed a sale of 9,025 common shares on February 6, 2026, for a total of $359,562. The transaction occurred at a weighted average price of $39.8407 per share. Hilltop recently reported fourth-quarter 2025 results that beat analyst expectations on both…
